The EU Makes Giant Strides towards the Proactive Publication of Clinical Trial Data
This section updates readers on the latest developments in pharmaceutical law, giving information on legislation and case law on various matters (such as clinical and pre-clinical trials, drug approval and marketing authorisation, the role of regulatory agencies) and providing analysis on how and to...
Saved in:
Published in | European journal of risk regulation Vol. 4; no. 1; pp. 80 - 82 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Cambridge, UK
Cambridge University Press
01.03.2013
Lexxion Verlagsgesellschaft mbH |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This section updates readers on the latest developments in pharmaceutical law, giving information on legislation and case law on various matters (such as clinical and pre-clinical trials, drug approval and marketing authorisation, the role of regulatory agencies) and providing analysis on how and to what extent they might affect health and security of the individual as well as in industry. [PUBLICATION ABSTRACT] |
---|---|
ISSN: | 1867-299X 2190-8249 |
DOI: | 10.1017/S1867299X00002828 |